Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins (Q44133912)

30 November 2017

title

Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins (English)

1 reference

adaptive radiation therapy

30 November 2017

main subject

0 references

adenocarcinoma

1 reference

pancreatic adenocarcinoma

inferred from title

1 reference

4

Herbert J Zeh

1 reference

30 November 2017

Nathan Bahary

6

1 reference

30 November 2017

Karlotta Ashby

7

1 reference

30 November 2017

Jean-Claude M. Rwigema

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809393

4 July 2024

Dwight E. Heron

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809393

4 July 2024

Simul D. Parikh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809393

4 July 2024

Herbert J. Zeh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809393

4 July 2024

James A. Moser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809393

4 July 2024

Steven A. Burton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20809393

4 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20809393

4 July 2024

publication date

1 March 2012

1 reference

Journal of gastrointestinal cancer

30 November 2017

published in

1 reference

30 November 2017

volume

43

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

70-76

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

30 November 2017

1 reference

One thousand consecutive pancreaticoduodenectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Margin clearance and outcome in resected pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Hospital volume and surgical mortality in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9203-7

Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.

21 January 2018

1 reference

12 December 2020

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

1 reference

12 December 2020

Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas

1 reference

12 December 2020

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma

1 reference

12 December 2020

Patterns of failure after curative resection of pancreatic carcinoma

1 reference

12 December 2020

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

1 reference

12 December 2020

Pancreatic fistula after pancreatic head resection

1 reference

12 December 2020

Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature.

1 reference

12 December 2020

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer

1 reference

12 December 2020

Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.

1 reference

12 December 2020

The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy

1 reference

12 December 2020

10.1007/S12029-010-9203-7

Identifiers

DOI

1 reference

30 November 2017

1 reference